Baxalta was a biopharmaceutical company that was spun off from Baxter International in 2015. It focused on developing therapies for hemophilia, immune deficiencies, and other medical needs. In 2016, Baxalta was acquired by Shire, which was later acquired by Takeda Pharmaceuticals.
Focus Areas
Notable Investments
